Tofacitinib in Active Ulcerative Colitis

被引：0
|
作者：
Cottone, Mario [1 ]
Orlando, Ambrogio [2 ]
Papi, Claudio [3 ]
机构：
[1] Univ Palermo, Palermo, Italy
[2] Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy
[3] Osped San Filippo Neri, Rome, Italy
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2012年 / 367卷 / 20期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1960 / 1960
页数：1
相关论文
共 50 条
  • [31] Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program
    Loftus, Edward V., Jr.
    Baumgart, Daniel C.
    Gecse, Krisztina
    Kinnucan, Jami A.
    Connelly, Susan B.
    Salese, Leonardo
    Su, Chinyu
    Kwok, Kenneth K.
    Woolcott, John C.
    Armuzzi, Alessandro
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (05) : 744 - 751
  • [32] Acute Pulmonary Embolism With Tofacitinib in Ulcerative Colitis
    Vyas, Anuj Y.
    Patel, Pranav
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1208 - S1208
  • [33] Tofacitinib, vedolizumab and ustekinumab in patients with ulcerative colitis
    Chang, Hui-Chin
    Gau, Shuo-Yan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 58 (11-12) : 1242 - 1242
  • [34] Tofacitinib in ulcerative colitis: a profile of its use
    Young-A Heo
    Drugs & Therapy Perspectives, 2020, 36 : 553 - 563
  • [35] The role and prospect of tofacitinib in patients with ulcerative colitis
    Lee, Jun
    INTESTINAL RESEARCH, 2022,
  • [36] COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN COLOMBIA
    Hansen, Tawnya
    Mak, Joyce
    Underwood, Fox
    Windsor, Joseph
    King, James
    Quan, Joshua
    Buie, Michael
    Coward, Stephanie
    Frolkis, Alex
    Leung, Alexander
    Ma, Christopher
    Novak, Kerri
    Panaccione, Remo
    Qian, Yiming
    Burisch, Johan
    Gearry, Richard
    Ng, Siew
    Kaplan, Gilaad
    INFLAMMATORY BOWEL DISEASES, 2022, 28 : S44 - S44
  • [37] Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance
    Nwaogu, Akudo
    Bond, Ashley
    Smith, Philip J.
    FRONTLINE GASTROENTEROLOGY, 2021, 12 (02) : 133 - 136
  • [38] Cost-effectiveness of tofacitinib for the treatment of moderate to severe active ulcerative colitis in Greece
    Vellopoulou, Katerina
    Stefanou, Garyfallia
    Tzanetakos, Charalampos
    Boubouchairopoulou, Nantia
    Nakou, Magdalini
    Gourzoulidis, George
    Kourlaba, Georgia
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (03) : 325 - 333
  • [39] Tofacitinib in active ulcerative colitis: Analysis of efficacy based on patient-reported outcomes
    Panes, J.
    Su, C.
    Bushmakin, A. G.
    Cappelleri, J. C.
    Mamolo, C.
    Healey, P.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S51 - S51
  • [40] COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE ULCERATIVE COLITIS IN COLOMBIA
    Gil, Fabio
    Julian-Banos, Fabian
    Amador, Luisa
    Castano, Natalia
    Reyes, Juan
    GASTROENTEROLOGY, 2022, 162 (03) : S44 - S44
12345